Company Name: Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of therapies for kidney disease using hypoxia-inducible factor (HIF) biology.
Ticker Symbol: AKBA (NASDAQ)
Company Website: http://akebia.com
Social Media:
Headquarters: Cambridge, MA